176 related articles for article (PubMed ID: 22309085)
1. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Inflamm Allergy Drug Targets; 2012 Feb; 11(1):66-78. PubMed ID: 22309085
[TBL] [Abstract][Full Text] [Related]
2. Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.
Toblli JE; Cao G; Angerosa M
Biometals; 2015 Apr; 28(2):279-92. PubMed ID: 25609135
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
Toblli JE; Cao G; Rivas C; Giani JF; Dominici FP
Int J Cardiol; 2016 Jun; 212():84-91. PubMed ID: 27038710
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose.
Elford P; Bouchard J; Jaillet L; Pearson N; Rogue A; Sabadie C; Forster R
J Pharmacol Toxicol Methods; 2013; 68(3):374-83. PubMed ID: 23624021
[TBL] [Abstract][Full Text] [Related]
5. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
Stein J; Dignass A; Chow KU
Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
[TBL] [Abstract][Full Text] [Related]
6. Differences between original intravenous iron sucrose and iron sucrose similar preparations.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2009; 59(4):176-90. PubMed ID: 19517894
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(7):399-410. PubMed ID: 21899208
[TBL] [Abstract][Full Text] [Related]
8. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Ziedan A; Bhandari S
Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
[TBL] [Abstract][Full Text] [Related]
9. Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.
Lee ES; Park BR; Kim JS; Choi GY; Lee JJ; Lee IS
Curr Med Res Opin; 2013 Feb; 29(2):141-7. PubMed ID: 23252876
[TBL] [Abstract][Full Text] [Related]
10. Do two intravenous iron sucrose preparations have the same efficacy?
Rottembourg J; Kadri A; Leonard E; Dansaert A; Lafuma A
Nephrol Dial Transplant; 2011 Oct; 26(10):3262-7. PubMed ID: 21355067
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the suitability of a Sprague Dawley rat model to assess intravenous iron preparations.
Span K; Pieters EHE; Brinks V; Hennink WE; Schellekens H
J Pharmacol Toxicol Methods; 2018; 91():7-17. PubMed ID: 29278742
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(10):553-65. PubMed ID: 22164963
[TBL] [Abstract][Full Text] [Related]
14. Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.
Toblli JE; Cao G; Angerosa M
Drug Des Devel Ther; 2015; 9():2585-97. PubMed ID: 26005335
[TBL] [Abstract][Full Text] [Related]
15. The Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model.
Toblli JE; Cao G; Angerosa M
J Clin Diagn Res; 2015 Dec; 9(12):FF08-12. PubMed ID: 26816915
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
Pieracci FM; Stovall RT; Jaouen B; Rodil M; Cappa A; Burlew CC; Holena DN; Maier R; Berry S; Jurkovich J; Moore EE
Crit Care Med; 2014 Sep; 42(9):2048-57. PubMed ID: 24797376
[TBL] [Abstract][Full Text] [Related]
17. Acute injury with intravenous iron and concerns regarding long-term safety.
Bishu K; Agarwal R
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
[TBL] [Abstract][Full Text] [Related]
18. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects.
Zheng H; Huang X; Zhang Q; Katz SD
Kidney Int; 2006 Feb; 69(4):679-84. PubMed ID: 16395269
[TBL] [Abstract][Full Text] [Related]
19. Markers of oxidative/nitrosative stress and inflammation in lung tissue of rats exposed to different intravenous iron compounds.
Toblli JE; Cao G; Giani JF; Dominici FP; Angerosa M
Drug Des Devel Ther; 2017; 11():2251-2263. PubMed ID: 28814833
[TBL] [Abstract][Full Text] [Related]
20. New rat models of iron sucrose-induced iron overload.
Vu'o'ng LĂȘ B; Khorsi-Cauet H; Villegier AS; Bach V; Gay-QuĂ©heillard J
Exp Biol Med (Maywood); 2011 Jul; 236(7):790-9. PubMed ID: 21685238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]